Cipher receives Patent Notice of Allowance for CIP-ISOTRETINOIN
Cipher Pharmaceuticals Inc. announced that the United States Patent and Trademark Office has issued a Patent Notice of Allowance for CIP-ISOTRETINOIN, the Company's novel formulation of the acne medication isotretinoin. The required issue and publication fees will now be paid so that the patent can be issued.
The patent includes claims related to the reduced food effect of CIP-ISOTRETIOIN relative to currently marketed formulations.
"Having the U.S. patent allowed represents an important milestone on our path to commercialization for CIP-ISOTRETINOIN," said Larry Andrews, President & CEO of Cipher. "It also reinforces that the product is truly differentiated from currently marketed formulations."
Most read news
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Tai_chi_chuan

New approach explains how protein complexes regulate cancer genes - New starting point for improved cancer therapies
Category:Pharmaceutical_microbiology
Cipher receives Patent Notice of Allowance for CIP-ISOTRETINOIN

More efficient biosolar cells modelled on nature - By combining light-collecting and photosynthesis proteins of different types, more energy can be produced

Australian skinks show researchers why some species have 'explosively' diversified over time
Stem-cell-growing surface enables bone repair
CHARGE_syndrome
Stretched, ordered DNA molecules could bring insights into disease
Study uncovers new hurdle for developing immunotherapies

How a molecular Superman protects the genome from damage - Scientists find a new role for RNAi protein Dicer in preventing collisions during DNA replication
